Raffaele Baffa
Chief Tech/Sci/R&D Officer chez CARSGEN THERAPEUTICS HOLDINGS LIMITED
Profil
Raffaele Baffa's career history includes current and former positions as well as education.
Currently, he is the Chief Medical Officer at CARsgen Therapeutics Holdings Ltd.
Previously, he held positions such as Director-Urology Research at Genito Urinary Medical Oncologists of Canada Gumo, Head-Translational Sciences at Sanofi, Inc., Vice President at Shire Pharmaceuticals LLC, Chief Medical Officer at Servier Pharmaceuticals LLC, and Chief Medical Officer at Alaunos Therapeutics, Inc. He also served as the Chief Medical Officer at Medisix Therapeutics, Inc. Dr. Baffa's education includes a doctorate from Providence College & Theological Seminary and the University of Parma.
Postes actifs de Raffaele Baffa
| Sociétés | Poste | Début |
|---|---|---|
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 07/04/2022 |
Anciens postes connus de Raffaele Baffa
| Sociétés | Poste | Fin |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
Servier Pharmaceuticals LLC
 Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company is based in Boston, MA. Servier Pharmaceuticals continues to build a treatment portfolio with a current focus on oncology within acute lymphoblastic leukemia. The company invests in innovative research and development through development or partnerships to best address the unmet needs of patients. Additionally, the company is proud to offer financial assistance to not only support patients and their families but a variety of focused advocacy groups and healthcare professionals as well. Servier Pharmaceuticals is committed to engaging with patients, caregivers, families, and patient organizations to ensure their voices are heard in every initiative. The company's responsibility is to help make the world a better place for patients and their families, and it strives to have consistent and concise transparency throughout all clinical trials and research and development for the benefit of all patients. The company was founded in 1954. The CEO is David K. Lee. | Chief Tech/Sci/R&D Officer | 01/03/2020 |
Shire Pharmaceuticals LLC
 Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Corporate Officer/Principal | 01/09/2018 |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a private company based in New York, NY. | Corporate Officer/Principal | 01/02/2018 |
| Genito Urinary Medical Oncologists of Canada Gumo | Corporate Officer/Principal | - |
Formation de Raffaele Baffa
| Providence College & Theological Seminary | Doctorate Degree |
| University of Parma | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| CARSGEN THERAPEUTICS HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 5 |
|---|---|
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a private company based in New York, NY. | Retail Trade |
Shire Pharmaceuticals LLC
Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Health Technology |
Servier Pharmaceuticals LLC
Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company is based in Boston, MA. Servier Pharmaceuticals continues to build a treatment portfolio with a current focus on oncology within acute lymphoblastic leukemia. The company invests in innovative research and development through development or partnerships to best address the unmet needs of patients. Additionally, the company is proud to offer financial assistance to not only support patients and their families but a variety of focused advocacy groups and healthcare professionals as well. Servier Pharmaceuticals is committed to engaging with patients, caregivers, families, and patient organizations to ensure their voices are heard in every initiative. The company's responsibility is to help make the world a better place for patients and their families, and it strives to have consistent and concise transparency throughout all clinical trials and research and development for the benefit of all patients. The company was founded in 1954. The CEO is David K. Lee. | Health Technology |
Medisix Therapeutics, Inc.
 Medisix Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Medisix Therapeutics, Inc. develops novel cellular therapies to address T cell malignancies. The company is headquartered in Singapore. | Commercial Services |
| Genito Urinary Medical Oncologists of Canada Gumo |
